Tirza Klein

Medicine & Life Sciences

1. Histocompatibility Antigens Class I 100%
2. HLA Antigens 89%
3. Immunologic Monitoring 79%
4. Transplants 64%
5. Transplant Recipients 62%
6. Chimerism 58%
7. Alleles 56%
8. Breast Neoplasms 48%
9. Tissue Donors 48%
10. Liver Transplantation 48%
11. Interleukin-2 46%
12. HLA-B52 Antigen 43%
13. Interferons 43%
14. Hepatitis C 42%
15. Cytokines 41%
16. Mycosis Fungoides 39%
17. Neoplasms 39%
18. HLA-B51 Antigen 38%
19. Unrelated Donors 38%
20. Serum 38%
21. Israel 37%
22. Haplotypes 34%
23. Recurrence 31%
24. Potassium Dichromate 31%
25. HLA-A2 Antigen 31%
26. Glutens 31%
27. Sutton disease 2 31%
28. Lymphocytes 31%
29. Histocompatibility Testing 30%
30. Nucleolus Organizer Region 29%
31. Living Donors 27%
32. ammonium trichloro(dioxoethylene-O,O'-)tellurate 27%
33. Celiac Disease 26%
34. Immunogenetics 26%
35. Mothers 26%
36. Cellular Immunity 26%
37. Habitual Abortion 26%
38. Anti-Idiotypic Antibodies 26%
39. Genes 25%
40. HLA-B38 Antigen 25%
41. Kidney Transplantation 24%
42. Hepacivirus 23%
43. Allogeneic Cells 22%
44. varespladib methyl 21%
45. Spontaneous Abortion 21%
46. Microsatellite Repeats 20%
47. Melanoma 20%
48. Jews 19%
49. Siblings 19%
50. HLA-B Antigens 19%